1. – Department Of Finance, Shih Chien University, Kaohsiung Campus, Taiwan.
| Received
01-Feb-2022 |
Accepted
- |
Published
01-Feb-2022 |
Abstract
Click Here:Access Full Text
This study discusses the impact of COVID-19 on the biotech industry vs. TSEC Taiwan 50 Components stocks. We found that the price of stocks in the biotech sector in Taiwan increased due to the COVID-19 pandemic. The financial leverage ratio did not significantly affect the stock price of biotech companies during the COVID-19 pandemic. The number of confirmed diagnosed cases in Taiwan decreases the stock price of biotech companies, for high ROA. In contrast, the number of confirmed diagnosed cases in Taiwan increases the stock price of biotech companies, for high ROE. Investors have more confidence in the biotech firms with shareholder returns during the COVID-19 pandemic.
This study discusses the impact of COVID-19 on the biotech industry vs. TSEC Taiwan 50 Components stocks. We found that the price of stocks in the biotech sector in Taiwan increased due to the COVID-19 pandemic. The financial leverage ratio did not significantly affect the stock price of biotech companies during the COVID-19 pandemic. The number of confirmed diagnosed cases in Taiwan decreases the stock price of biotech companies, for high ROA. In contrast, the number of confirmed diagnosed cases in Taiwan increases the stock price of biotech companies, for high ROE. Investors have more confidence in the biotech firms with shareholder returns during the COVID-19 pandemic.
Locked
Subscribed
Open Access
Open Access